Biocross, S.L. has developed diagnostic systems that use reliable blood-based methods to diagnose neurodegenerative diseases, which can be applied in hospital settings and provide patients with a reduced cost of risk assessment and diagnosis of these diseases. The company's focus is on the diagnosis of Alzheimer's disease, and their tests are designed to be used by neurologists to provide accurate and reliable results. Biocross's innovative approach to diagnosing Alzheimer's disease has the potential to greatly improve patient outcomes and reduce the burden of this devastating disease on individuals and families.